Equity Overview
Price & Market Data
Price: $2.77
Daily Change: -$0.11 / 3.97%
Daily Range: $2.76 - $2.88
Market Cap: $2,448,927
Daily Volume: 32,425
Performance Metrics
1 Week: -4.08%
1 Month: -26.37%
3 Months: -7.24%
6 Months: -46.23%
1 Year: -67.25%
YTD: -58.89%
Company Details
Employees: 3
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
As of May 16, 2025, Protagenic Therapeutics, Inc. was acquired by Phytanix Bio, Inc., in a reverse merger transaction. Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.